CoChat

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern

Open access
Goel, Rishi R., Painter, Mark M., Apostolidis, Sokratis A., Mathew, Divij, Meng, Wenzhao, Rosenfeld, Aaron M., Lundgreen, Kendall A., Reynaldi, Arnold, Khoury, David S., Pattekar, Ajinkya, Gouma, Sigrid, Kuri-Cervantes, Leticia, Hicks, Philip, Dysinger, Sarah, Hicks, Amanda, Sharma, Harsh, Herring, Sarah, Korte, Scott, Baxter, Amy E., Oldridge, Derek A., Giles, Josephine R., Weirick, Madison E., McAllister, Christopher M., Awofolaju, Moses, Tanenbaum, Nicole, Drapeau, Elizabeth M., Dougherty, Jeanette, Long, Sherea, D’Andrea, Kurt, Hamilton, Jacob T., McLaughlin, Maura, Williams, Justine C., Adamski, Sharon, Kuthuru, Oliva, The UPenn COVID Processing Unit, Frank, Ian, Betts, Michael R., Vella, Laura A., Grifoni, Alba, Weiskopf, Daniela, Sette, Alessandro, Hensley, Scott E., Davenport, Miles P., Bates, Paul, Luning Prak, Eline T., Greenplate, Allison R., Wherry, E. John · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
PreprintCited by 59

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

SARS-CoV-2 mRNA vaccines have shown remarkable efficacy, especially in preventing severe illness and hospitalization. However, the emergence of several variants of concern and reports of declining antibody levels have raised uncertainty about the durability of immune memory following vaccination. In this study, we longitudinally profiled both antibody and cellular immune responses in SARS-CoV-2 naïve and recovered individuals from pre-vaccine baseline to 6 months post-mRNA vaccination. Antibody and neutralizing titers decayed from peak levels but remained detectable in all subjects at 6 months post-vaccination. Functional memory B cell responses, including those specific for the receptor binding domain (RBD) of the Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.2) variants, were also efficiently generated by mRNA vaccination and continued to increase in frequency between 3 and 6 months post-vaccination. Notably, most memory B cells induced by mRNA vaccines were capable of cross-binding variants of concern, and B cell receptor sequencing revealed significantly more hypermutation in these RBD variant-binding clones compared to clones that exclusively bound wild-type RBD. Moreover, the percent of variant cross-binding memory B cells was higher in vaccinees than individuals who recovered from mild COVID-19. mRNA vaccination also generated antigen-specific CD8+ T cells and durable memory CD4+ T cells in most individuals, with early CD4+ T cell responses correlating with humoral immunity at later timepoints. These findings demonstrate robust, multi-component humoral and cellular immune memory to SARS-CoV-2 and current variants of concern for at least 6 months after mRNA vaccination. Finally, we observed that boosting of pre-existing immunity with mRNA vaccination in SARS-CoV-2 recovered individuals primarily increased antibody responses in the short-term without significantly altering antibody decay rates or long-term B and T cell memory. Together, this study provides insights into the generation and evolution of vaccine-induced immunity to SARS-CoV-2, including variants of concern, and has implications for future booster strategies. GRAPHICAL ABSTRACT:

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.08.23.457229

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 42

  1. T. Carvalho , F. Krammer , A. Iwasaki , The first 12 months of COVID-19: a timeline of immunological insights. Nat. Rev. Immunol., 1–12 (2021). · DOI · Paper page
  2. 10.1038/s41591-021-01377-8 · DOI · Paper page
  3. 10.1101/2021.08.11.21261876 · DOI
  4. 10.1101/2021.08.09.21261290 · DOI
  5. N. Doria-Rose , M. S. Suthar , M. Makowski , S. O’Connell , A. B. McDermott , B. Flach , J. E. Ledgerwood , J. R. Mascola , B. S. Graham , B. C. Lin , S. O’Dell , S. D. Schmidt , A. T. Widge , V.-V. Edara , E. J. Anderson , L. Lai , K. Floyd , N. G. Rouphael , V. Zarnitsyna , P. C. Roberts , M. Makhene , W. Buchanan , C. J. Luke , J. H. Beigel , L. A. Jackson , K. M. Neuzil , H. Bennett , B. Leav , J. Albert , P. Kunwar , mRNA-1273 Study Group, Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. N. Engl. J. Med., NEJMc2103916 (2021). · DOI · Paper page
  6. 10.1056/NEJMOA2109072 · DOI · Paper page
  7. 10.1101/2021.08.03.21261496 · DOI
  8. 10.1101/2021.07.28.21261159 · DOI · Paper page
  9. 2021, SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses, Nat, 2021, 1
  10. 2021, Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination, Sci. Immunol, 6, 1
  11. 10.1101/2021.07.29.454333 · DOI · Paper page
  12. 10.1016/J.IMMUNI.2021.08.001 · DOI · Paper page
  13. 10.1016/J.XCRM.2021.100355 · DOI · Paper page
  14. 10.1101/2021.06.30.21259787 · DOI · Paper page
  15. 2021, Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection, Nat. Rev. Immunol, 21, 395, 10.1038/s41577-021-00550-x · DOI · Paper page
  16. 10.1038/s41577-019-0244-2 · DOI · Paper page
  17. 10.1101/2021.08.20.21262158 · DOI · Paper page
  18. 2021, Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells, Cell Reports Med, 2, 100354, 10.1016/j.xcrm.2021.100354 · DOI · Paper page
  19. D. A. Collier , A. De Marco , I. A. T. M. Ferreira , B. Meng , R. Datir , A. C. Walls , S. A. Kemp S , J. Bassi , D. Pinto , C. S. Fregni , S. Bianchi , M. A. Tortorici , J. Bowen , K. Culap , S. Jaconi , E. Cameroni , G. Snell , M. S. Pizzuto , A. F. Pellanda , C. Garzoni , A. Riva , A. Elmer , N. Kingston , B. Graves , L. E. McCoy , K. G. C. Smith , J. R. Bradley , N. Temperton , L. Lourdes Ceron-Gutierrez , G. Barcenas-Morales , W. Harvey , H. W. Virgin , A. Lanzavecchia , L. Piccoli , R. Doffinger , M. Wills , D. Veesler , D. Corti , R. K. Gupta , Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature, 1–8 (2021). · DOI · Paper page
  20. 2021, Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera, Cell, 189, 1
  21. 10.1016/J.CELL.2021.06.020 · DOI · Paper page
  22. 10.1016/j.cell.2021.03.013 · DOI · Paper page
  23. L. Stamatatos , J. Czartoski , Y.-H. Wan , L. J. Homad , V. Rubin , H. Glantz , M. Neradilek , E. Seydoux , M. F. Jennewein , A. J. MacCamy , J. Feng , G. Mize , S. C. De Rosa , A. Finzi , M. P. Lemos , K. W. Cohen , Z. Moodie , M. J. McElrath , A. T. McGuire , mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science (80-.)., eabg9175 (2021). · DOI · Paper page
  24. 10.1126/science.abh1282 · DOI · Paper page
  25. 10.1038/ni.3533 · DOI · Paper page
  26. 10.1016/j.jim.2013.02.009 · DOI
  27. S. Gouma , M. E. Weirick , M. J. Bolton , C. P. Arevalo , E. C. Goodwin , E. M. Anderson , C. M. McAllister , S. R. Christensen , D. Dunbar , D. Fiore , A. Brock , J. Weaver , J. S. Millar , S. DerOhannessian , I. Frank , D. J. Rader , E. J. Wherry , S. E. Hensley , Health care worker sero-monitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration. JCI Insight, 446 (2021). · DOI
  28. 10.1126/science.abe1107 · DOI · Paper page
  29. 10.1128/mBio.00939-20 · DOI · Paper page
  30. 2020, SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness, Nat, 586, 567, 10.1038/s41586-020-2622-0 · DOI · Paper page
  31. 10.1038/S41467-021-24123-7 · DOI · Paper page
  32. D. HL, S. CT, L. L, C. S, A. NW, H. PJ, Z. NY, H. M, S. DG, C. MS, E. SA, G. JJ, S. O, W. J, W. ES, M. ML, S. K, J. MO, A. F, S. I, U. HA, H. J, N. CA, D. YN, H. PD, J. RP, J. A, K. F, D. MS, F. DH, K. Y, W. PC, 2021, Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets, Immunity, 54, 1290, 10.1016/j.immuni.2021.05.001 · DOI · Paper page
  33. 10.3389/fimmu.2018.01472 · DOI · Paper page
  34. C. Gaebler , Z. Wang , J. C. C. Lorenzi , F. Muecksch , S. Finkin , M. Tokuyama , A. Cho , M. Jankovic , D. Schaefer-Babajew , T. Y. Oliveira , M. Cipolla , C. Viant , C. O. Barnes , Y. Bram , G. Breton , T. Hägglöf , P. Mendoza , A. Hurley , M. Turroja , K. Gordon , K. G. Millard , V. Ramos , F. Schmidt , Y. Weisblum , D. Jha , M. Tankelevich , G. Martinez-Delgado , J. Yee , R. Patel , J. Dizon , C. Unson-O’Brien , I. Shimeliovich , D. F. Robbiani , Z. Zhao , A. Gazumyan , R. E. Schwartz , T. Hatziioannou , P. J. Bjorkman , S. Mehandru , P. D. Bieniasz , M. Caskey , M. C. Nussenzweig , Evolution of antibody immunity to SARS-CoV-2. Nature, 1–6 (2021). · DOI
  35. 10.1126/SCIIMMUNOL.ABD5709 · DOI · Paper page
  36. 10.1038/nbt.3942 · DOI · Paper page
  37. 10.1126/sciimmunol.abd7114 · DOI · Paper page
  38. 10.1093/bioinformatics/btu138 · DOI · Paper page
  39. 10.1093/nar/gkt382 · DOI · Paper page
  40. 10.1093/bioinformatics/btw593 · DOI
  41. 2018, ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data, Front. Immunol, 9, 2107, 10.3389/fimmu.2018.02107 · DOI · Paper page
  42. 10.1093/molbev/msw046 · DOI · Paper page

Cited by

See all 59

Metadata

Authors
Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., Gouma, S., Kuri-Cervantes, L., Hicks, P., Dysinger, S., Hicks, A., Sharma, H., Herring, S., Korte, S., Baxter, A. E., Oldridge, D. A., Giles, J. R., Weirick, M. E., McAllister, C. M., Awofolaju, M., Tanenbaum, N., Drapeau, E. M., Dougherty, J., Long, S., D’Andrea, K., Hamilton, J. T., McLaughlin, M., Williams, J. C., Adamski, S., Kuthuru, O., Unit, T. U. C. P., Frank, I., Betts, M. R., Vella, L. A., Grifoni, A., Weiskopf, D., Sette, A., Hensley, S. E., Davenport, M. P., Bates, P., Luning Prak, E. T., Greenplate, A. R., & Wherry, E. J.
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2021-08-23
OpenAlex
W3194838263
Cited by
59
References
15
Type
posted content
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. https://app.cochat.ai/papers/10.1101/2021.08.23.457229
The paper
Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., Gouma, S., Kuri-Cervantes, L., Hicks, P., Dysinger, S., Hicks, A., Sharma, H., Herring, S., Korte, S., Baxter, A. E., . . . Wherry, E. J. (2021). mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2021.08.23.457229

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.